Funding, M&A and exec moves matched to your market, from $49/mo billed annually, or $79/mo quarterly. See plans and pricing.See plans →
$3M Partnership to Accelerate Development of Neuroplastogens for Substance Use Disorder Treatment
Oct 28, 2024•almost 2 years ago
Contract Type
partnership
BoulderBiotechnologyHealth CareTherapeuticsDescription
Tessara Therapeutics, Psylo, and the University of Sydney have secured a $3 million grant to advance brain-rewiring treatments for addiction. The collaboration will focus on the development of neuroplastogens for the treatment of substance use disorders, with an emphasis on methamphetamine addiction, aiming to provide faster, more effective treatments for addiction and other mental health conditions.
Agreement Insights
Based on industry dataStrategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months
Tessara Therapeutics Psylo and the University of Sydney signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.